Fulgent Genetics raises 2025 revenue guidance to $325M as new products drive growth (NASDAQ:FLGT)
Group 1 - The article does not provide any specific content related to a company or industry [1]
Group 1 - The article does not provide any specific content related to a company or industry [1]